Clinical trial
Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors
NCT00301782 · Medical Research Council, Other · Completed
Key facts
| NCT number | NCT00301782 |
|---|---|
| Title | Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors |
| Official title | Randomized Phase II Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP Chemotherapy in Poor Prognosis Male Germ Cell Tumors |
| Lead sponsor | Medical Research Council, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Extragonadal Germ Cell Tumor, Teratoma, Testicular Germ Cell Tumor |
| Intervention type | Biological, Drug |
| Interventions | bleomycin sulfate, carboplatin, cisplatin, etoposide phosphate, vincristine sulfate |
| Enrollment | 88 |
| Start date | Jun 1, 2005 |
| Completion | Jun 1, 2010 |
| First posted | Mar 13, 2006 |
| Last update posted | Aug 26, 2013 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: